﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Tabriz University of Medical Sciences</PublisherName>
      <JournalTitle>Advanced Pharmaceutical Bulletin</JournalTitle>
      <Issn>2228-5881</Issn>
      <Volume>16</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2026</Year>
        <Month>09</Month>
        <DAY>30</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>pH-Sensitive Folate-Targeted Liposomal Vitamin D Reprograms EZH2/STAT3 Axis and Induces Apoptosis, ROS, and Autophagy in MCF-7 Breast Cancer Cells</ArticleTitle>
    <FirstPage>550</FirstPage>
    <LastPage>561</LastPage>
    <ELocationID EIdType="doi">10.34172/apb.46791</ELocationID>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Soheil</FirstName>
        <LastName>Abbaspour-Ravasjani</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0001-7541-1638</Identifier>
      </Author>
      <Author>
        <FirstName>Rahim</FirstName>
        <LastName>Shahvalizadeh</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-9940-5539</Identifier>
      </Author>
      <Author>
        <FirstName>Malahat</FirstName>
        <LastName>Safavi</LastName>
        <Identifier Source="ORCID">https://orcid.org/0009-0001-6883-0188</Identifier>
      </Author>
      <Author>
        <FirstName>Mina</FirstName>
        <LastName>Afrashteh Nour</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0001-6781-1092</Identifier>
      </Author>
      <Author>
        <FirstName>Mahdi</FirstName>
        <LastName>Talebi</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-3633-2280</Identifier>
      </Author>
      <Author>
        <FirstName>Maryam</FirstName>
        <LastName>Mohammadi</LastName>
      </Author>
      <Author>
        <FirstName>Hamed</FirstName>
        <LastName>Hamishehkar</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0001-9905-0662</Identifier>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">10.34172/apb.46791</ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2025</Year>
        <Month>11</Month>
        <Day>20</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2026</Year>
        <Month>06</Month>
        <Day>22</Day>
      </PubDate>
    </History>
    <Abstract>Introduction: Vitamin D3 (Vit D3) possesses pleiotropic anticancer activity; however, its clinical application is limited by poor bioavailability and nonselective cellular uptake. This study aimed to develop folate (FA)-targeted, pH-sensitive liposomes for enhanced delivery of Vit D3 to breast cancer cells and to evaluate their effects on the VDR/EZH2/STAT3 signaling axis. Methods: Vit D3-loaded pH-sensitive liposomes were formulated and characterized for particle size, zeta potential, encapsulation efficiency, stability, and pH-responsive release. Cellular uptake, cytotoxicity, clonogenicity, apoptosis, reactive oxygen species (ROS) generation, autophagy, cell-cycle distribution, RT-qPCR, and Western blotting were evaluated in MCF-7 cells. Results: The optimized formulations exhibited nanoscale particle size, high encapsulation efficiency, physicochemical stability, and enhanced acidic pH-triggered release. FA-targeted liposomes significantly increased cellular uptake and cytotoxicity compared with free Vit D3 and non-targeted liposomes, with IC50 values of 15, 11, and 7.2 IU·mL-1, respectively. Vit D3-PEG/lipo-FA induced a 3.2-fold upregulation of VDR expression while suppressing EZH2 and STAT3 expression by 60% and 50%, respectively. In addition, treatment increased Caspase-3, LC3B, and NOX4 expression, promoted apoptosis and ROS generation, altered cell-cycle progression, and markedly reduced clonogenic survival. Western blot analysis confirmed these molecular alterations at the protein level. Conclusion: FA-targeted pH-sensitive liposomal delivery significantly enhances the anticancer efficacy of Vit D3 in MCF-7 cells by modulating the VDR/EZH2/STAT3 axis and activating apoptosis-, autophagy-, and ROS-associated pathways, highlighting its potential as a targeted nanotherapeutic strategy for breast cancer treatment.  </Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">pH-sensitive liposomes</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Vitamin D3</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Breast cancer</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Folate targeting</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">MCF-7 cells</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>